Celltaxis
PrivateLast Round
Series A
Jun 4, 2026
Total Funding Raised
$46M
Company Overview
Celltaxis is a clinical-stage biotechnology company developing pharmaceutical therapies targeting lymphatic dysfunction, including lymphedema and lipedema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celltaxis Comparables
Compare Celltaxis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 77% | |
| Herantis Pharma Oyj | 70% | |
| PureTech Health | 68% |
Celltaxis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 4, 2026 | ||||
| Seed | Mar 31, 2020 |
Celltaxis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Masters Capital Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2020
Seed round led by Masters Capital Management.
Celltaxis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Celltaxis's valuation, stock price, and market status.
Is Celltaxis a public or private company?
Celltaxis is a private company.
What is the current stock price of Celltaxis?
Celltaxis is a private company with no public stock price. Caplight tracks Celltaxis's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Celltaxis worth (valuation)?
Valuation information for Celltaxis is not publicly available.
Can I buy Celltaxis stock?
Celltaxis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Celltaxis's last funding round?
Celltaxis's most recent funding round was Series A on June 4, 2026.
Who are the main investors in Celltaxis?
Key investors in Celltaxis include Masters Capital Management.
Will Celltaxis IPO soon?
No public IPO plans have been announced for Celltaxis.
How can I track Celltaxis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celltaxis's secondary market activity and sign up for updates.